Delivery Order SPE2DB20D2014-SPE2DB24FC61Y
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,154.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $16,318.05 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is to supply the DLA with Vraylar 3 mg capsules, a medication used for the treatment of mental health conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $22,390.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Vraylar 1.5 mg capsules, a medication used to treat various mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.94 delivery order contract is for the supply of Vraylar 1.5 mg capsules, a medication used in the treatment of mental health conditions. The contract has an ultimate completion date of December 30, 2024 and is structured as a firm fixed-price agreement. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $3,558.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, a prescription medication, over a performance period ending on April 9, 2025. The contract is a firm-fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial...
This is a $2,293.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of January 8, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The contract has a ceiling value of $7,930.97 and a period of performance through April 2025. It is a firm-fixed price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,151.88 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a medication used in the treatment of mental health conditions. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,452.25 firm fixed-price contract is for the delivery of Vraylar 4.5 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,403.29 contract is for the delivery of Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of June 18, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...